Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas
- aDepartment of Immunology, University of Toronto, Medical Sciences Building, Toronto, Canada M5S 1A8; and
- bDepartment of Cell Biology, Albert Einstein College of Medicine, Michael F. Price Center, 1301 Morris Park Avenue, Bronx, NY 10461
-
Edited by Matthew D. Scharff, Albert Einstein College of Medicine, Bronx, NY, and approved September 16, 2009 (received for review June 7, 2009)
Abstract
C-Myc is one of the most common targets of genetic alterations in human cancers. Although overexpression of c-Myc in the B cell compartment predisposes to lymphomas, secondary mutations are required for disease manifestation. In this article, we show that genetic deficiencies causing arrested B cell development and accumulation of B cell progenitors lead to accelerated lymphomagenesis in Eμ c-myc transgenic mice. This result suggests that B cell progenitors are more prone than their mature counterparts to developing secondary oncogenic lesions that complement c-Myc in promoting transformation. To investigate the nature of these oncogenic lesions, we examined Eμ c-myc mice deficient in mismatch repair function. We report that Msh2−/− Eμ c-myc and Msh2G674A/G674A Eμ c-myc mice rapidly succumb to pro-B cell stage lymphomas, indicating that Msh2-dependent mismatch repair function actively suppresses c-Myc-associated oncogenesis during early B cell development.
Footnotes
- 1To whom correspondence should be addressed. E-mail: alberto.martin{at}utoronto.ca
-
Author contributions: R.M.N. and A.M. designed research; R.M.N., L.T., and B.K. performed research; W.E. contributed new reagents/analytic tools; R.M.N., L.T., and A.M. analyzed data; and R.M.N., W.E., and A.M. wrote the paper.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0905965106/DCSupplemental.








